Relationship between DNA repair capacity and resistance to genotoxins in four human cell lines

Cancer Detection and Prevention

Volumn 27, Issue 1, 2003, Pages 24-29

  Atanassov, Boyko S ^a   Ninova, Petia D ^a   Anachkova, Boyka B ^a   Russev, George C ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Bulgaria)

Author keywords

Biomarkers; Cell survival; DNA repair; Fluorescent host cell reactivation assay

Indexed keywords

GREEN FLUORESCENT PROTEIN; MUTAGENIC AGENT; PHOTOPROTEIN;

ANIMAL; ARTICLE; CELL DEATH; COMPARATIVE STUDY; DNA DAMAGE; DNA REPAIR; DOSE RESPONSE; DRUG EFFECT; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; METHODOLOGY; PHYSIOLOGY; PLASMID; RADIATION EXPOSURE; SPECTROFLUOROMETRY;

ANIMALS; CELL DEATH; DNA DAMAGE; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LUMINESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; MUTAGENS; PLASMIDS; SPECTROMETRY, FLUORESCENCE; TRANSFECTION;

EID: 0037225019     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-090X(02)00175-7     Document Type: Article

References (41)

1. Fox M, Roberts JJ. Drug resistance and DNA repair. Cancer Metastasis Rev 1987;6:261-81.
2. Burt RK, Poirier MC, Link Jr CJ, Bohr VA. Antineoplastic drug resistance and DNA repair. Ann Oncol 1991;2:325-34.
3. Colvin OM. Drug resistance in the treatment of sarcomas. Semin Oncol 1997;24:580-91.
4. Rajewsky M, Engelberg J, Thomale J, Schweer T. DNA repair: counteragent in mutagenesis and carcinogenesis-accomplice in cancer therapy resistance. Mutat Res 2000;462:101-5.
5. Terheggen PM, Emondt JY, Floot BG, Dijkman R, Schrier PI, den Engelse L, et al. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of cis-diamminedichloroplatinum(II)-DNA antiserum. Cancer Res 1990;50:3556-61.
6. Ali-Osman F, Berger MS, Rajagopal S, Spence A, Livingston RB. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin induced DNA interstrand crosslinks and cytotoxicity in human glioblastoma cells. Cancer Res 1993;53:5663-8.
7. Zeng-Rong N, Paterson J, Alpert L, Tsao MS, Viallet J, Alaoui-Jamali MA. Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy. Cancer Res 1995;55:4760-4.
8. De Pooter CM, Van Oosterom AT, Scalliet PG, Maes RA, de Bruijn EA. Correlation of the response to cisplatin of human ovarian cancer cell lines, originating from one tumor but with different sensitivity, with the recovery of DNA adducts. Biochem Pharmacol 1996;51:629-34.
9. Jaekle KA, Eyre HJ, Townsend J, Schulman S, Knudson HM, Belanich M, et al. Correlation of tumor O6-methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest oncology group study. J Clin Oncol 1998;16:3310-5.
10. Lagre H, Christmann M, Kern MA, Dietel M, Pick M, Kaina B, et al. Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosilase in melanoma cells with acquired drug resistance. Int J Cancer 1999;80:744-50.
11. Runger T, Emmet S, Schadendorf D, Diem C, Epe B, Hellfritsch D. Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fortemustine, or etoposite. J Invest Dermatol 2000;114:34-9.
12. Frankfurt OS. Inhibition of DNA repair and enhancement of cytotoxicity of alkylating agents. Int J Cancer 1991;48:916-23.
13. Sun Y, Moses RE. Reactivation of psoralen-reacted plasmid DNA in Fanconi anemia, xeroderma pigmentosum, and normal human fibroblast cells. Somat Cell Mol Genet 1991;17:229-38.
14. O'Driscoll M, Macpherson P, Xu Y, Karran P. The cytotoxicity of DNA carboxymethylation and methylation by the model carboxymethylating agent azaserine in human cells. Carcinogenesis 1999;20:1855-62.
15. Lannon C, Ball L, Pyesmany A, Yhap M, Langley G, van Velzen D. Demonstration of differences in drug resistance by direct testing of DNA excision repair activity following standard and lyposomal daunorubicin exposure in normal paediatric marrow using high resolution CLSM. Adv Exp Med Biol 1999;457:509-16.
16. Abbot DW, Freeman ML, Holt JT. Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J Natl Cancer Inst 1998;90:978-85.
17. Roy G, Horton J, Roy R, Denning T, Mitra S, Boldogh I. Acquired alkylating drug resistance of a human ovarian carcinoma cell line is unaffected by altered levels of pro- and anti-apoptotic proteins. Oncogene 2000;19:141-50.
18. Bohr VA, Smith CD, Okumoto DS, Hanawalt PC. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 1985;40:359-69.
19. Ploskonosova II, Baranov VI, Gaziev AI. PCR assay of DNA damage and repair at the gene level in brain and spleen of gamma-irradiated young and old rats. Mutat Res 1999;434:109-17.
20. Yang H, Kotturi GP, de Boer JG, Glickman BW. Measurement of DNA damage and repair in the lambda LIZ transgene in a Big Blue rat cell line by quantitative PCR. Environ Mol Mutagen 1999;33:21-7.
21. Barret J-M, Calsou P, Salles B. Deficient nucleotide excision repair activity in protein extracts from normal human lymphocytes. Carcinogenesis 1995;16:1611-6.
22. Sallas B, Rodrigo G, Li RY, Calsou P. DNA damage excision repair in microplate wells with chemiluminescence detection: development and perspectives. Biochimie 1999;81:53-8.
23. Barret J-M, Calsou P, Laurent G, Salles B. DNA repair activity in protein extracts of fresh human malignant lymphoid cells. Mol Pharmacol 1966;49:766-71.
24. Collins AR, Dobson VL, Dusinska M, Kennedy G, Stetina R. The comet assay: what can it really tells us? Mutat Res 1997;375:183-93.
25. Protic-Sabljie M, Kraemer KH. Host cell reactivation by human cells of DNA expression vectors damaged by ultraviolet radiation or by acid-heat treatment. Carcinogenesis 1986;7:765-70.
26. Henderson EE, Valerie K, Green A, Riel J. Host cell reactivation of CAT-expression vectors as a method to assay for cloned DNA-repair genes. Mutat Res 1989;220:151-60.
27. Athas W, Hedayati M, Matonoski G, Farmer E, Grossman L. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res 1991;51:5786-93.
28. Wei Q, Matanoski G, Farmer E, Hedayati M, Grossman L. DNA repair related to multiple skin cancer and drug use. Cancer Res 1994;54:437-40.
29. Roguev A, Russev G. A two wave-length fluorescence assay for DNA repair. Anal Biochem 2000;287:313-8.
30. Fichtinger-Schepman AMJ, van der Veer JL, den Hartog JHJ, Lohman PHM, Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry 1985;24:707-13.
31. Gunz D, Hess M, Naegeli H. Recognition of DNA adducts by human nucleotide excision repair. J Biol Chem 1996;271:25089-98.
32. Thomson RJ, Mosig G. Light affects the structure of Chlamydomonas chloroplast chromosomes. Nucleic Acids Res 1990;18:2625-31.
33. Dall'Acqua F, Vedaldi D, Bordin F, Rodighiero G. New studies on the interaction between 8-methoxypsoralen and DNA in vitro. J Invest Dermatol 1979;73:191-7.
34. Mamet-Bratley MD, Karska-Wysocki B. Toxicity and repair of psoralen adducts in bacteriophage T7. J Photochem Photobiol B 1997;38:48-53.
35. Kyrtopoulos SA. Variability in DNA repair and individual susceptibility to genotoxins. Clin Chem 1995;41:1848-53.
36. Wei Q, Spitz MR. The role of DNA repair capacity in susceptibility to lung cancer. Cancer Metastasis Rev 1997;16:295-307.
37. Collins AR. Molecular epidemiology in cancer research. Mol Aspects Med 1998;19:359-432.
38. Ankathil R, Jyothish B, Madhavan J, Nair MK. Deficient DNA repair capacity: a predisposing factor and high risk predictive marker in familial colorectal cancer. J Exp Clin Cancer Res 1999;18:33-7.
39. Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, et al. Loss of mismatch repair in acquired resistance to cisplatin. Cancer Res 1996;56:3087-90.
40. Levati L, Marra G, Lettieri T, D'Atri S, Vernole P, Tentori L, et al. Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents. Genes Chromosomes Cancer 1998;23:159-66.
41. Goodman M, Tippin B. The expanding polymerase universe. Nat Rev 2000;1:101-9.